Waters Corporation (WAT) recently experienced notable activities in stock positions, with several entities acquiring and selling shares. Wealthfront, Fjarde AP Fonden, and Shell Asset Management increased stake, while Bessemer Group, Logan Capital and others trimmed their holdings. Waters announced the launch of Charge Detection Mass Spectrometry technology and a deal to acquire BD's Biosciences & Diagnostic Solutions Business, indicating a focus on high-volume testing and efforts to accelerate next-gen biotherapeutics development. Waters also revealed improved Q1 and Q2 sales figures, raising future expectations. However, the company's shares seemed unpredictable, showing both positive and negative trends. Highlighted as a top growth stock, Waters' performance remains under scrutiny due to challenges such as the Becton Dickinson Unit merger. Despite such risks, Rothschild Redburn initiated a 'buy' rating while TD Cowen reduced its price target. Waters' recent business activities included software enhancements, increased stake in the India weight-loss drugs market, and the acquisition of Halo Labs. The company's stock dipped slightly post the better-than-expected Q2 results announcement but its long-term outlook remained positive.
Waters Corp WAT News Analytics from Wed, 12 Feb 2025 08:00:00 GMT to Sat, 01 Nov 2025 08:02:10 GMT - Rating 4 - Innovation 7 - Information 8 - Rumor -3
